175 related articles for article (PubMed ID: 28024479)
1. [Construction of Eukaryotic Expression Vector of siRNA Specific for BCR/ABL Fusion Gene and Its Effects on K562 Cells].
Li M; Wang BL; Wang LN; Xi YM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1698-1704. PubMed ID: 28024479
[TBL] [Abstract][Full Text] [Related]
2. [Construction of eukaryotic expression vector of siRNA specific to bcr/abl fusion gene].
Xi YM; Liu T; Meng WT; Wang YH; Gu L; Lu XX; Gong YP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):460-3. PubMed ID: 16078560
[TBL] [Abstract][Full Text] [Related]
3. [Effects of specific siRNA targeting at bcr-abl fusion gene and its combination with p27 gene clone on chronic myeloid leukemia cell line K562].
Wang W; DU Y; Lin GQ; Li NN; Sun BZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):606-11. PubMed ID: 20561411
[TBL] [Abstract][Full Text] [Related]
4. [Effect of specific siRNA targeting against bcr-abl chimeric gene on chronic myelogenous leukemia cells].
Wang S; Chai YB; Liu F; Zhang XY; Jia W; Xie X; Yu WQ; Shang ZC; Jin BQ; Sun BZ
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):198-202. PubMed ID: 15854468
[TBL] [Abstract][Full Text] [Related]
5. BCR/ABL mRNA targeting small interfering RNA effects on proliferation and apoptosis in chronic myeloid leukemia.
Zhu XS; Lin ZY; Du J; Cao GX; Liu G
Asian Pac J Cancer Prev; 2014; 15(12):4773-80. PubMed ID: 24998540
[TBL] [Abstract][Full Text] [Related]
6. [Knockdown of Alox5 gene promotes apoptosis of K562/ADM cells].
Luo Y; Xu M; Gao W; Tao K
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Oct; 33(10):1398-1403. PubMed ID: 29169426
[TBL] [Abstract][Full Text] [Related]
7. [Experimental study of K562 cell apoptosis induced by siRNA].
Chen BB; Fan HH; Lin GW; Yuan ZH; Lu HZ; Gao L; Liu Y
Zhonghua Xue Ye Xue Za Zhi; 2004 Dec; 25(12):717-9. PubMed ID: 15730712
[TBL] [Abstract][Full Text] [Related]
8. [Inhibitory effect of RNA interference on chronic myeloid leukemia bcr/abl oncogene expression].
Ma XX; Wang C; Wei J; Qin YW; Yan SK; Gao YR; Cai Q
Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):359-62. PubMed ID: 16185484
[TBL] [Abstract][Full Text] [Related]
9. Bcr-abl silencing by specific small-interference RNA expression vector as a potential treatment for chronic myeloid leukemia.
Zaree Mahmodabady A; Javadi HR; Kamali M; Najafi A; Hojati Z
Iran Biomed J; 2010; 14(1-2):1-8. PubMed ID: 20683492
[TBL] [Abstract][Full Text] [Related]
10. [Construction of retrovirus vector of bcr/abl mRNA cleaving ribozyme gene and its effects on K562 cells].
Wu Y; Chen Y; Hu J
Zhonghua Xue Ye Xue Za Zhi; 1998 Dec; 19(12):623-6. PubMed ID: 11263328
[TBL] [Abstract][Full Text] [Related]
11. Study on the treatment of the p15 gene combined with Bcr-abl-specific siRNA and STI571 for chronic myeloid leukemia.
Wang W; Du Y; Li NN; Lv FF; Lin GQ
Genet Mol Res; 2014 May; 13(2):4089-101. PubMed ID: 24938701
[TBL] [Abstract][Full Text] [Related]
12. [Effects of berbamine on K562 cells and its mechanisms in vitro and in vivo].
Wu D; Lin MF; Zhao XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):373-8. PubMed ID: 15972123
[TBL] [Abstract][Full Text] [Related]
13. [Inhibitory effect of siRNA on bcr-abl gene expression in K562 cell line].
Jiang L; Wu JB; Yu K; Ni WH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Jun; 12(3):332-4. PubMed ID: 15228661
[TBL] [Abstract][Full Text] [Related]
14. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable charged polyester-based vectors (BCPVs) as an efficient non-viral transfection nanoagent for gene knockdown of the BCR-ABL hybrid oncogene in a human chronic myeloid leukemia cell line.
Yang C; Panwar N; Wang Y; Zhang B; Liu M; Toh H; Yoon HS; Tjin SC; Chong PH; Law WC; Chen CK; Yong KT
Nanoscale; 2016 Apr; 8(17):9405-16. PubMed ID: 27092903
[TBL] [Abstract][Full Text] [Related]
16. [Construction of genetically modified dendritic cell vaccine expressing bcr/abl fusion gene and inducing specific cytotoxic T lymphocytes to kill K562 cells in vitro].
Wang WW; Huang RW; Hu Y; Li XD; Wang DN; He Y; Liu JJ
Ai Zheng; 2009 Jun; 28(6):602-6. PubMed ID: 19635197
[TBL] [Abstract][Full Text] [Related]
17. [The study of inhibitory and apoptosis of K562 cells by antisense oligodeoxynucleotides].
Shi QZ; Lu LH; Hu JD; Chen YY; Yang YL
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2001 Aug; 17(3):213-6. PubMed ID: 21189610
[TBL] [Abstract][Full Text] [Related]
18. miRNA143 Induces K562 Cell Apoptosis Through Downregulating BCR-ABL.
Liang B; Song Y; Zheng W; Ma W
Med Sci Monit; 2016 Aug; 22():2761-7. PubMed ID: 27492780
[TBL] [Abstract][Full Text] [Related]
19. [Effect of targeted activation of protein kinase PKR on proliferation of leukemia cell line K562 and its mechanism].
Zhao SQ; Feng WL; Zeng JM; Bai WJ; Wang XZ; Wen JP; Cao WX; Luo YP; Huang ZG
Ai Zheng; 2007 Oct; 26(10):1058-63. PubMed ID: 17927873
[TBL] [Abstract][Full Text] [Related]
20. Suppression of bcr-abl synthesis by siRNAs or tyrosine kinase activity by Glivec alters different oncogenes, apoptotic/antiapoptotic genes and cell proliferation factors (microarray study).
Zhelev Z; Bakalova R; Ohba H; Ewis A; Ishikawa M; Shinohara Y; Baba Y
FEBS Lett; 2004 Jul; 570(1-3):195-204. PubMed ID: 15251464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
